written by reader Jeff Brown Crispr Based Pitch to Cure Blindness

By docdavidw, May 22, 2020

Jeff Brown is pushing Exponential Tech Investor ($2000 for a year) with a tease for a small biotech expected to enter stage 1 for an injection DNA cure for blindness caused by a genetic disorder. He expects an announcement as soon as today (it didn’t happen) that will cause the stock to at least double with much further advances on rapidly moving to stage 2. I did some research and concluded that the company is Editas (EDIT). It looked sufficiently promising for me to buy some stock and options. Thoughts?

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

2
Share your thoughts...

avatar
1 Comment threads
1 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
2 Comment authors
bankbustersZeflik Recent comment authors

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Zeflik
Member
๐Ÿ‘68

Yes it is EDIT. He gives the same pitch regularly to sell his investment letter. I personally invest in EDIT and its competitor CRSP.

bankbusters
Member
๐Ÿ‘0
bankbusters

These biotech stocks he recommends are solid overall. Lots of due diligence done by them. I have found they tend to spike on news of course but regularly pops when the bio company presents at conferences. Now they present digitally due to Covid 19.